Lv4
494 积分 2025-07-30 加入
Complete Regression of Hepatoblastoma after Interleukin-15- and Interleukin-21-Coexpressing CAR T-Cell Therapy
13天前
已完结
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial
20天前
已完结
The Landscape of Clinical Trials for Claudin18.2-Positive Gastric Cancer
21天前
已完结
Preclinical Development and a Case Report of a Nanobody-Based CLDN18.2 CAR-T IMC002 with Reduced On-Target Off-Tumor Toxicity
21天前
已关闭
Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer
21天前
已完结
Claudin proteins as emerging therapeutic targets for solid tumours
22天前
已完结
The Landscape of Clinical Trials for Claudin18.2-Positive Gastric Cancer
22天前
已完结
Impact of concomitant medications on efficacy of CLDN18.2-specific CAR-T cell therapy in advanced gastric cancer
22天前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
29天前
已完结
Nikanjam M, et al. Claudin 18.2 Targeting: A Pan-Cancer Perspective. Clinical Cancer Research,
30天前
已完结
皖公网安备34019202002308
